Procter & Gamble PG BABY, FEMININE & FAMILY CARE — Cost incurred

Other segment segments

Similar metrics at other companies

USNACore nutritional — Cost realignment

$1.62M—

HAEApheresis — Costs incurred, net of reversals

$13K+103%

HAECorporate — Costs incurred, net of reversals

-$24K-102%

HAEMedSurg — Costs incurred, net of reversals

$2.31M+301%

ENRAuto Care — Restructuring costs

$900K-52.6%

XPO

XPOEuropean Transportation — Charges Incurred

$4M-55.6%

FAQ

What is Procter & Gamble's BABY, FEMININE & FAMILY CARE — cost incurred?

Procter & Gamble (PG) reported BABY, FEMININE & FAMILY CARE — cost incurred of $10M in Q2 2025.

How has Procter & Gamble's BABY, FEMININE & FAMILY CARE — cost incurred changed year-over-year?

Procter & Gamble's BABY, FEMININE & FAMILY CARE — cost incurred decreased by 20.0% year-over-year, from $12.5M to $10M.

What is the long-term trend for Procter & Gamble's BABY, FEMININE & FAMILY CARE — cost incurred?

Over 3 years (2022 to 2025), Procter & Gamble's BABY, FEMININE & FAMILY CARE — cost incurred has grown at a -21.6% compound annual growth rate (CAGR), from $83M to $40M.

What does BABY, FEMININE & FAMILY CARE — cost incurred mean?

This metric represents specific non-recurring or project-based operational costs attributed to the Baby, Feminine & Family Care segment. It captures expenditures related to strategic initiatives, restructuring, or specific operational adjustments that are distinct from standard cost of goods sold or recurring administrative expenses. Monitoring these costs helps investors understand the impact of temporary operational shifts or targeted investments on the segment's overall profitability.